ICI-174864
ICI-174864
ICI-174864 is a selective antagonist of the 5-HT2 receptor, specifically targeting the 5-HT2A and 5-HT2C subtypes. It is a compound of interest in the field of neuropharmacology due to its potential applications in research and therapeutic contexts.
Chemical Structure and Properties[edit]
ICI-174864 is a chemical compound with the molecular formula C19H22N2O2. It is characterized by its selective binding affinity to the 5-HT2A and 5-HT2C receptors, which are subtypes of the serotonin receptor family. These receptors are G protein-coupled receptors (GPCRs) that play a crucial role in the modulation of neurotransmission in the central nervous system.
Mechanism of Action[edit]
As a selective antagonist, ICI-174864 binds to the 5-HT2A and 5-HT2C receptors, inhibiting the action of serotonin (5-HT) at these sites. This blockade can modulate various physiological and psychological processes, including mood, perception, and cognition. The selective antagonism of these receptors makes ICI-174864 a valuable tool in research for understanding the role of serotonin in the brain.
Research Applications[edit]
ICI-174864 is primarily used in preclinical research to study the function of 5-HT2 receptors. It has been employed in experiments to:
- Investigate the role of 5-HT2 receptors in psychiatric disorders such as schizophrenia, depression, and anxiety disorders.
- Explore the effects of serotonin on cognition and perception.
- Examine the potential therapeutic effects of 5-HT2 receptor modulation in various neurological disorders.
Therapeutic Potential[edit]
While ICI-174864 itself is not used as a therapeutic agent, its role as a research tool helps in the development of new drugs targeting the 5-HT2 receptors. Understanding the interaction between serotonin and these receptors can lead to the development of novel treatments for mental health disorders.
Safety and Toxicology[edit]
As with many research chemicals, the safety profile of ICI-174864 is not fully established for human use. It is primarily used in controlled laboratory settings, and its effects in humans are not well-documented.
Also see[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
